US Stocks
US Options
Emerging Asia
GBP Cash Savings
Charts & Tools
Paper Trading
Extended Hours
Wall Street Journal
TradingViewT
TXMD
Therapeuticsmd Inc
1.74
0.13+8.07%After Hours: 1.630 -0.11 -6.32%17:42 12/05 EST
OPEN/PREV CLOSE1.600/1.610
TODAY RANGE1.455-1.740
VOL146.53K
MARKET CAP20.14M
52 WEEK RANGE0.7000-2.440
AVG VOL (3M)221.50K
% TURNOVER1.27%
TURNOVER--
P/E (TTM)66.67
% RANGE17.70%
EPS(TTM)0.0261
P/E(FORWARD)11.60
P/B0.7338
BVPS2.371
DIVIDEND--
P/S11.39
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP19.83M
SHARES OUTSTANDING11.57M
NEXT EARNINGS03/25-03/30
FREE FLOAT11.40M
LOT SIZE1
EX-DATE05/09/2022
News
Press Releases
Financial Reports
Profile
Dow Jones·1d ago
TherapeuticsMD Inc. Stock Climbs 8.1%, Outperforms Market
Dow Jones·3d ago
TherapeuticsMD Inc. Stock Climbs 8.9%, Outperforms Market
Dow Jones·4d ago
TherapeuticsMD Inc. Stock Sheds 3.9%, Underperforms Market
Dow Jones·5d ago
TherapeuticsMD Inc. Stock Sheds 10.6%, Underperforms Market
Dow Jones·11/20 21:33
TherapeuticsMD Inc. Stock Climbs 16.4%, Outperforms Market
Dow Jones·11/19 21:32
TherapeuticsMD Inc. Stock Rallies 7.1%, Outperforms Market
Benzinga·11/19 17:06
12 Health Care Stocks Moving In Wednesday's Intraday Session
Dow Jones·11/17 21:33
TherapeuticsMD Inc. Stock Slides 22.4%, Underperforms Market
TipRanks·11/13 11:32
TherapeuticsMD Reports Q3 2025 Financial Results
Seeking Alpha·11/13 05:24
Therapeutics MD GAAP EPS of $0.00
Benzinga·11/12 21:31
TherapeuticsMD Q3 Sales $784.000K Up From $547.000K YoY
Reuters·11/12 21:24
TherapeuticsMD swings to Q3 profit, license revenue climbs
Reuters·11/12 21:07
TherapeuticsMD Reports Q3 Net Income of $50,000 on $784,000 License Revenue
Seeking Alpha·11/10 17:40
FDA to remove “black box” warnings on hormone therapies for menopause
Same Industry
Name/Symbol
Change%
Price